• HMM News

Hydroxychloroquine (HCQ): Setting The Record Straight

Updated: Mar 29

We’ve all seen the countless reports, articles and news stories bashing President Trump for promoting the use of Hydroxychloroquine + zinc, touting it as a cure for COVID-19, the disease caused by the novel SARS-Coronavirus.

The problem is that it seems like almost every article contradicts the last, and possesses an unparalleled level of bias in a seemingly choreographed effort to label the President as irresponsible for supporting the use of this decades old treatment.

Earlier today, Lee Moran of the Huffington Post, a bleeding-heart agenda-fueling cess-pool of media bias and piss-poor journalism, published a story discussing statements made by MSNBC’s “Morning Joe” co-host Joe Scarborough (another MSM hack), declaring that the President’s statements w/r/t the use of HCQ and the inquiry into the use of disinfectants (we’ll save the disinfectants for another story) would likely be earmarked in history as his downfall, should the President lose the upcoming 2020 Presidential Election.

After reading the Lee Moran story today, I felt compelled to set the record straight on this subject, once and for all. In order to do this, I feel it would be most effective if I presented you with some of my background in the healthcare landscape so that you can at least have some faith that I know what I am talking about.

I have worked in the healthcare industry for the last 5 years, starting my career in the pharmacy marketing arena building referral networks, but quickly moved into consulting independent physicians and automating clinic management operations. Over the last 3 years, I have opened an integrated clinic, a medical billing and coding company, and founded multiple healthcare startups focused on the development of telehealth and mhealth technologies. One of the most recent products I developed was a telehealth application that helped to facilitate inter-operational workflows between genetic testing laboratories, ordering physicians, insurers and the patients themselves.

One of the contracts my physician consulting organization held was that of Clinical Trials Management and Principle Investigator (P.I.) recruitment. Our duties outlined in this contract were to recruit physicians to participate in clinical research trials (mainly Phase III trials), assist them in applying for and securing trials, and training them on the proper methods of collecting and documenting their investigative research data, as well as how to properly interpret the subsequent reports.

Ok, so now that you know I at least have some inkling of an idea as to what I’m talking about (unlike most of these mainstream media hacks), let’s have a look at some the data behind Hydroxychloroquine.

Hydroxychloroquine (HCQ) belongs to a family of drugs known as “antimalarials” (Ams), which are classified as Disease-Modifying Anti-Rheumatic Drugs (DMARDs). This class of drugs was first used to treat Cutaneous Lupus as early as 1834. Hydroxychloroquine (HCQ) and Chloroquine (CQ) were first synthesized in the mid 1940’s, and by 1955 HCQ had shown to be effective in the treatment of Systemic Lupus and Rheumatoid Arthritis.

“In 1956, the U.S. Food and Drug Administration approved HCQ for symptoms of lupus and rheumatoid arthritis, particularly skin inflammation, hair loss, mouth sores, fatigue, and joint pain.”lupus.org

Common side-effects in patients taking HCQ include gastrointestinal issues like nausea, vomiting, upset stomach and diarrhea, although these typically subside after j